Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.27%AUDUSD-1.08%GBPCHF+0.98%GBPCAD+0.84%USDCHF+0.77%AUDJPY-0.74%EURGBP-0.68%USDCAD+0.66%AUDNZD-0.63%GBPNZD+0.63%EURAUD+0.60%USDTHB+0.58%GBPJPY+0.55%EURUSD-0.50%NZDUSD-0.46%AUDCAD-0.45%GBPTRY+0.41%CHFJPY-0.38%USDJPY+0.36%PLNJPY+0.33%AUDCHF-0.33%NZDCHF+0.33%GBPHKD+0.32%CADJPY-0.29%GBPMXN-0.28%USDTRY+0.28%EURCHF+0.27%NOKJPY+0.27%SGDJPY+0.23%NZDCAD+0.20%GBPUSD+0.19%USDCNH-0.17%USDILS+0.16%EURCAD+0.16%CHFSGD+0.14%EURJPY-0.14%NZDMXN+0.13%NZDSGD+0.12%CADCHF+0.12%CHFNOK+0.11%GBPZAR+0.10%GBPSGD+0.09%AUDSGD+0.09%EURSGD+0.08%EURZAR+0.08%NZDJPY-0.08%USDMXN+0.07%EURCNH+0.07%AUDNOK+0.06%USDSEK-0.06%USDPLN-0.06%EURNOK+0.05%CHFSEK+0.05%USDDKK-0.05%USDZAR+0.04%USDSGD+0.04%USDCOP-0.04%EURCZK-0.04%USDHKD+0.04%EURHKD+0.03%EURNZD-0.03%EURPLN-0.02%EURSEK-0.01%USDNOK0.00%EURDKK0.00%AUDDKK0.00%USOIL-0.40%HG1-0.40%XPTUSD-0.31%XAGUSD+0.30%GAGUSD+0.29%W1+0.29%UKOIL-0.26%C1+0.18%S1-0.14%XNGUSD-0.11%XAUUSD+0.05%GAUUSD+0.05%BTCUSD-0.07%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.01%ZECUSDT+0.65%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.78%XLMUSD+3.07%BCHUSDT-0.16%UNIUSD-0.25%LTCUSD+0.07%HBARUSDT+1.91%SUIUSD+2.24%TONUSD+15.77%TAOUSDT+0.33%AAVEUSD-3.33%DOTUSDT+3.62%ICPUSDT-3.03%ONDOUSDT+0.93%WLDUSDT+10.92%ARBUSDT-0.13%JUPUSDT-0.20%ATOMUSDT+1.57%INJUSDT-2.35%STXUSDT+21.33%FETUSDT+4.52%SEIUSDT+0.33%PYTHUSDT-2.19%TIAUSDT+0.39%IMXUSDT+1.58%GRTUSDT+0.46%OPUSDT+1.31%WIFUSDT+3.87%IOTAUSDT+4.12%POLUSDT-4.20%AXSUSDT+1.11%FARTCOINUSDT-0.23%EOSUSDT+4.71%DYDXUSDT+3.97%GALAUSDT+6.11%ORDIUSDT+1.64%NOTUSDT+1.55%RONINUSDT+1.63%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.27%AUDUSD-1.08%GBPCHF+0.98%GBPCAD+0.84%USDCHF+0.77%AUDJPY-0.74%EURGBP-0.68%USDCAD+0.66%AUDNZD-0.63%GBPNZD+0.63%EURAUD+0.60%USDTHB+0.58%GBPJPY+0.55%EURUSD-0.50%NZDUSD-0.46%AUDCAD-0.45%GBPTRY+0.41%CHFJPY-0.38%USDJPY+0.36%PLNJPY+0.33%AUDCHF-0.33%NZDCHF+0.33%GBPHKD+0.32%CADJPY-0.29%GBPMXN-0.28%USDTRY+0.28%EURCHF+0.27%NOKJPY+0.27%SGDJPY+0.23%NZDCAD+0.20%GBPUSD+0.19%USDCNH-0.17%USDILS+0.16%EURCAD+0.16%CHFSGD+0.14%EURJPY-0.14%NZDMXN+0.13%NZDSGD+0.12%CADCHF+0.12%CHFNOK+0.11%GBPZAR+0.10%GBPSGD+0.09%AUDSGD+0.09%EURSGD+0.08%EURZAR+0.08%NZDJPY-0.08%USDMXN+0.07%EURCNH+0.07%AUDNOK+0.06%USDSEK-0.06%USDPLN-0.06%EURNOK+0.05%CHFSEK+0.05%USDDKK-0.05%USDZAR+0.04%USDSGD+0.04%USDCOP-0.04%EURCZK-0.04%USDHKD+0.04%EURHKD+0.03%EURNZD-0.03%EURPLN-0.02%EURSEK-0.01%USDNOK0.00%EURDKK0.00%AUDDKK0.00%USOIL-0.40%HG1-0.40%XPTUSD-0.31%XAGUSD+0.30%GAGUSD+0.29%W1+0.29%UKOIL-0.26%C1+0.18%S1-0.14%XNGUSD-0.11%XAUUSD+0.05%GAUUSD+0.05%BTCUSD-0.07%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.01%ZECUSDT+0.65%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.78%XLMUSD+3.07%BCHUSDT-0.16%UNIUSD-0.25%LTCUSD+0.07%HBARUSDT+1.91%SUIUSD+2.24%TONUSD+15.77%TAOUSDT+0.33%AAVEUSD-3.33%DOTUSDT+3.62%ICPUSDT-3.03%ONDOUSDT+0.93%WLDUSDT+10.92%ARBUSDT-0.13%JUPUSDT-0.20%ATOMUSDT+1.57%INJUSDT-2.35%STXUSDT+21.33%FETUSDT+4.52%SEIUSDT+0.33%PYTHUSDT-2.19%TIAUSDT+0.39%IMXUSDT+1.58%GRTUSDT+0.46%OPUSDT+1.31%WIFUSDT+3.87%IOTAUSDT+4.12%POLUSDT-4.20%AXSUSDT+1.11%FARTCOINUSDT-0.23%EOSUSDT+4.71%DYDXUSDT+3.97%GALAUSDT+6.11%ORDIUSDT+1.64%NOTUSDT+1.55%RONINUSDT+1.63%
NU

Nuvalent, Inc. (NUVL)

NASDAQ • Healthcare

$123.96
+$0 (+0.0%)
Market closed

Last close at July 21, 2026 at 20:00 UTC

Open$123.96
Day Range$123.96 - $123.96
Avg. Volume (3M)0
Market Cap$9.1B
52 Week Range
$81.02$123.99

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$450M
EPS (TTM)
-$6.06
ROA (TTM)
-33.81%
Current Ratio
16.14

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-22.3%Q4 2025-$1.7
+12.8%Q1 2026-$1.29
-3.0%Q2 2026-$1.39

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q2 2026
Miss -3.0%

Nuvalent’s EPS trailed consensus in the preliminary first fiscal quarter of 2026 reported on May 7, with EPS of -$1.39 versus the -$1.35 estimate, -3.0%. Net income was a loss of about $109.3 million, down 29% from a loss of $84.6 million a year ago, and EPS was down 32% from -$1.05 a year ago. Operating income came in at negative about $119.4 million, while operating cash flow was negative about $92.4 million. Next-period consensus calls for EPS of -$1.44 on revenue of $245,455.00.

View full earnings history

About Nuvalent, Inc.

Nuvalent, Inc. develops targeted cancer therapies as a clinical-stage Biotechnology company listed on the NASDAQ as NUVL. The company centers its pipeline on kinase inhibitors for genetically defined tumors, and, in qualitative terms, it remains an early-stage drug developer rather than a commercial oncology company.

Name
Nuvalent, Inc.
CEO
James R. Porter
Website
www.nuvalent.com
Industry
Healthcare
Year Founded
2017
Employees
234

Today's Snapshot

AI-generated

NUVL closed flat at 123.96, while its sector was weaker. At the close, NUVL was within 0% of its 52-week high of 123.99.

vs S&P 500 Today

Moderate Underperformance

-0.19%

Updated: September 30, 2026 at 20:08 UTC

Technical Indicators

5 Buy2 Neutral1 Sell
NUVL trades at 123.96 and displays a bullish technical profile driven by a strong directional trend and broad moving-average support. ADX reading above 35 indicates a robust trend, while momentum measures are mixed with RSI showing sustained strength and MACD mildly positive, and some oscillators nearing overbought. The stock sits at or just above its short- and medium-term averages and longer-term moving averages remain supportive, and volume-based OBV points to accumulation. Volatility is modest per ATR, which underlines orderly upside rather than erratic moves. Technical takeaway: Strong Buy.
All signals
  • EMA (5 indicators)$104.24 - $123.82
    Buy
  • RSI (14)67.59
    Neutral
  • Stochastic %K (14, 3, 3)94.39
    Sell
  • MACD Level (12, 26)2.51
    Neutral

Peers & Related Assets

JAZZJazz Pharmaceuticals plc
$231.52-0.4%
AXSMAxsome Therapeutics, Inc.
$184.39-0.9%
ARWRArrowhead Pharmaceuticals, Inc.
$65.45-1.2%
PCVXVaxcyte, Inc.
$56.9+0.4%
CYTKCytokinetics, Incorporated
$65.91+0.4%
RYTMRhythm Pharmaceuticals, Inc.
$95.22-0.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.